Paul E. Gross
2021
In 2021, Paul E. Gross earned a total compensation of $1.2M as EVP and General Counsel at Clovis Oncology, a 11% decrease compared to previous year.
Compensation breakdown
| Bonus | $183,237 |
|---|---|
| Salary | $486,260 |
| Stock Awards | $504,630 |
| Other | $22,385 |
| Total | $1,196,512 |
Gross received $504.6K in stock awards, accounting for 42% of the total pay in 2021.
Gross also received $183.2K in bonus, $486.3K in salary and $22.4K in other compensation.
Rankings
In 2021, Paul E. Gross' compensation ranked 8,127th out of 12,415 executives tracked by ExecPay. In other words, Gross earned more than 34.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,127 out of 12,415 | 35th |
Division Manufacturing | 3,592 out of 5,508 | 35th |
Major group Chemicals And Allied Products | 1,596 out of 2,378 | 33rd |
Industry group Drugs | 1,420 out of 2,099 | 32nd |
Industry Pharmaceutical Preparations | 1,055 out of 1,549 | 32nd |
Pay ratio
| Paul E. Gross' Pay | $1,196,512 |
|---|---|
| Median Employee's Pay | $246,936 |
| Pay Ratio | 5to 1 |
In 2021, the annual total compensation of Paul E. Gross was $1,196,512.
The annual total compensation of the median employee at Clovis Oncology was $246,936.
The ratio of Paul E. Gross' pay to the pay of median employee was therefore 5 to one.
Source: SEC filing on April 27, 2022.
Gross' colleagues
We found four more compensation records of executives who worked with Paul E. Gross at Clovis Oncology in 2021.